Skip to main content
. 2019 Jan 28;98(4):813–822. doi: 10.1007/s00277-018-03592-9

Table 1.

Compare of clinical trials about BCMA CAR-T cells

graphic file with name 277_2018_3592_Tab1_HTML.jpg

SD, stable disease; PR, partial response; VGPR, very good partial response; sCR, stringent complete response; PD, progressive disease; MR, minimal response; CR, complete response